Keywords: Europe, CHMP, Boehringer Ingelheim, Twynsta, Teva, Plavix, GlaxoSmithKline, Rotarix Sanofi Pasteur, Rotateq, Leo Pharma, Daivobet
Europe’s CHMP recommends approval of Boehringer Ingelheim’s Twynsta and Teva’s generic Plavix; updates on rotavirus vaccines
Article | 26 July 2010
The European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
